New Delhi/Moscow: The Russian government is apparently considering the plea of a desperate father from Uttar Pradesh in India to include his 21-year-old son – a Stage-IV cancer patient – in its vaccine trials.

Russia is developing an mRNA-based cancer vaccine known as Enteromix – designed to train the immune system to recognize and destroy cancer cells. ADVERTISEMENT

According to news reports, the vaccine uses a personalized approach, based on the genetic profile of a patient’s tumour. The vaccine has apparently shown promising results in initial trials by shrinking tumours and slowing their growth.

Manu Srivastava from Lucknow said that when he got to know about the vaccine, he wrote to Moscow. He also wrote to the Indian government to help expedite the process.

Srivastava claims tha

See Full Page